Panagora Asset Management’s Armata Pharmaceuticals ARMP Stock Holding History

Panagora Asset Management’s Portfolio ARMP Stock Details ARMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-10,409	Closed	-$42K	–	2468
2019 Q2	$42K	Sell	10,409 -851	-8%	-$3.26K	﹤0.01%	2119
2019 Q1	$47K	Buy	11,260 +1,238	+12%	+$4.71K	﹤0.01%	2051
2018 Q4	$29K	Buy	10,022 +7,014	+233%	+$34.2K	﹤0.01%	2125
2018 Q3	$43K	Sell	3,008 -144	-5%	-$2.1K	﹤0.01%	2047
2018 Q2	$50K	Buy	3,152 +1,392	+79%	+$22.7K	﹤0.01%	2038
2018 Q1	$27K	Buy	1,760 +436	+33%	+$7.73K	﹤0.01%	2161
2017 Q4	$19K	Buy	1,324 +1,040	+366%	+$15.4K	﹤0.01%	2173
2017 Q3	$4K	Sell	284 -64	-18%	-$820	﹤0.01%	2265
2017 Q2	$4K	Hold	348	–	–	﹤0.01%	2517
2017 Q1	$21K	Hold	348	–	–	﹤0.01%	2168
2016 Q4	$18K	Hold	348	–	–	﹤0.01%	2236
2016 Q3	$68K	Buy	+348	New	+$80.2K	﹤0.01%	2056

Other funds holding ARMP

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

GWM

Geneos Wealth Management Englewood, Colorado $4.31B AUM 18.36% 1-Year Est. Return

Panagora Asset Management's ARMP Position: Q3 2019 in Review

Panagora Asset Management sold out of Armata Pharmaceuticals (ARMP) in Q3 2019, closing a stake of 10,409 shares — an estimated $42K sold.

Panagora Asset Management first reported a position in ARMP in Q3 2016 and held it in 12 quarters. The position peaked at $68K in Q3 2016. 14 funds tracked by Wall St. Rank hold ARMP as of Q3 2019.

Panagora Asset Management reported no remaining Armata Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
Panagora Asset Management sold 10,409 Armata Pharmaceuticals shares in Q3 2019, an estimated $42K.
Panagora Asset Management first reported a position in Armata Pharmaceuticals in Q3 2016 and held it in 12 quarters.
Panagora Asset Management's Armata Pharmaceuticals position peaked at $68K in Q3 2016.
14 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q3 2019.

Based on Panagora Asset Management's 13F filing for Q3 2019, filed 12 Nov 2019.